| Page 1326 | Kisaco Research
 

Per Falk

President
Ferring Pharmaceuticals

Per Falk

President
Ferring Pharmaceuticals

Per Falk

President
Ferring Pharmaceuticals
 

Zack Mummery

Partner
Reddie & Grose

Zack is a partner at Reddie & Grose and is a UK and European patent attorney based in London.

Zack assists large multinational corporations, SMEs and start-ups operating at the cutting edge of chemistry and pharmaceutical technologies.  

Zack has a wealth of experience drafting new patent applications and managing large patent portfolios covering developed and emerging markets. Zack regularly provides clear commercially focussed advice on global patent strategies, utilising patent protection and managing the risk posed by third party patent rights.

Zack Mummery

Partner
Reddie & Grose

Zack Mummery

Partner
Reddie & Grose

Zack is a partner at Reddie & Grose and is a UK and European patent attorney based in London.

Zack assists large multinational corporations, SMEs and start-ups operating at the cutting edge of chemistry and pharmaceutical technologies.  

Zack has a wealth of experience drafting new patent applications and managing large patent portfolios covering developed and emerging markets. Zack regularly provides clear commercially focussed advice on global patent strategies, utilising patent protection and managing the risk posed by third party patent rights.

Zack also has experience supporting clients through funding rounds, assisting clients with investor due diligence and he has provided IP support for a number of large deals including a multimillion dollar public offering.

 

Mimi Yen

CEO & Co-Founder
PhagePro Inc.

Dr. Yen is a 2018 MIT Technology Review Innovator Under 35 and a microbiologist with a global health and program management background. Since co-founding PhagePro, Dr. Yen has received numerous awards and won several startup competitions recognizing her innovative leadership in global health, such as the ASTMH Innovations Pitch Competition and LaunchBio's The Big Pitch. She has been selected for several fellowships, including the MassNextGen Fellowship for women-led early-stage life science businesses, The Capital Network Female Founder Fellowship, and the Henri Termeer Legacy Program.

Mimi Yen

CEO & Co-Founder
PhagePro Inc.

Mimi Yen

CEO & Co-Founder
PhagePro Inc.

Dr. Yen is a 2018 MIT Technology Review Innovator Under 35 and a microbiologist with a global health and program management background. Since co-founding PhagePro, Dr. Yen has received numerous awards and won several startup competitions recognizing her innovative leadership in global health, such as the ASTMH Innovations Pitch Competition and LaunchBio's The Big Pitch. She has been selected for several fellowships, including the MassNextGen Fellowship for women-led early-stage life science businesses, The Capital Network Female Founder Fellowship, and the Henri Termeer Legacy Program. An advocate for DEI in both biotech and global health communities, Dr. Yen strives to center the voices and the needs of the most marginalized.

Innovation Showcase Cheat Sheet
Innovation Showcase Cheat Sheet
Innovation Showcase Finalists
 

Franco Costantini

CEO
regenagri

Franco Costantini

CEO
regenagri

Franco Costantini

CEO
regenagri
 

Shawn Frederick

Senior Director, Medical Sciences
Organogenesis

Shawn Frederick

Senior Director, Medical Sciences
Organogenesis

Shawn Frederick

Senior Director, Medical Sciences
Organogenesis
 

Laura Yecies

CEO & Founder
Bone Health Technologies

Laura Yecies is the CEO of Bone Health Technologies, maker of OsteoBoost, the first effective and safe non-drug treatment for low bone density.  Previously she was CEO of SyncThink a medical diagnostic company, Catch, which she sold to Apple and SugarSync which was acquired by J2Global.  Earlier she led the Browser division at Netscape, was general manager of Yahoo Mail and VP of Marketing at Check Point.  Ms.

Laura Yecies

CEO & Founder
Bone Health Technologies

Laura Yecies

CEO & Founder
Bone Health Technologies

Laura Yecies is the CEO of Bone Health Technologies, maker of OsteoBoost, the first effective and safe non-drug treatment for low bone density.  Previously she was CEO of SyncThink a medical diagnostic company, Catch, which she sold to Apple and SugarSync which was acquired by J2Global.  Earlier she led the Browser division at Netscape, was general manager of Yahoo Mail and VP of Marketing at Check Point.  Ms. Yecies has led commercialization and product development programs that have resulted in the use by over 350m customers.  She received her MBA from Harvard, has an MSFS from Georgetown and her AB in Government Magna Cum Laude from Dartmouth.   She has been profiled in the NYTimes and multiple periodicals and is a prolific speaker and writer on health care and technology.